Rare incidence of non-secretory myeloma with talaromycosis: a case report
Open Access
- 16 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12879-021-06641-3
Abstract
Talaromyces marneffei (TM) primarily infects patients with co-morbidities that cause immunodeficiency, but non-secretory myeloma (NSMM) is rare. TSM and NSMM are associated with fever, osteolysis, and swollen lymph nodes, thereby making it difficult for clinicians to make differential diagnosis. In this case, we describe TM infection coexisting with NSMM. We retrospectively reviewed the case of a male (without human immunodeficiency virus infection) with fever, thoracalgia, swollen lymph nodes, and subcutaneous nodules who presented to the First Affiliated Hospital of Guangxi Medical University in February 2014. Chest computed tomography revealed patchy infiltration and positron emission tomography/computed tomography showed increased metabolic activity in the lower-right lung, lymph nodes, left ninth rib, and right ilium. Pathological examination of the lung, lymph nodes, subcutaneous nodules, and bone marrow showed no malignancy, he was diagnosed with community-acquired pneumonia. His clinical symptoms did not improve after anti-bacterial, anti-Mycobacterium tuberculosis, and anti-non-M. tuberculosis treatment. Later, etiological culture and pathological examination of the subcutaneous nodule proved TM infection, and the patient was re-diagnosed with disseminated TSM, which involved the lungs, lymph nodes, skin, bone, and subcutaneous tissue. After antifungal treatment, the patient showed significant improvement, except for the pain in his bones. Imaging showed aggravated osteolysis, and bone marrow biopsy and immunohistochemistry indicated NSMM. Thus, we conclusively diagnosed the case as NSMM with TSM (involving the lungs, lymph nodes, skin, and subcutaneous tissue). His condition improved after chemotherapy, and he was symptom-free for 7 years. TM infection is rare in individual with NSMM. Since they have clinical manifestation in common, easily causing misdiagnosis and missed diagnosis, multiple pathological examinations and tissue cultures are essential to provide a differential diagnosis.Funding Information
- National Natural Science Foundation of China (2015GXNSFAA139189)
This publication has 15 references indexed in Scilit:
- Talaromyces (Penicillium) marneffei infection in non-HIV-infected patientsEmerging Microbes & Infections, 2016
- Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective studyBMC Infectious Diseases, 2015
- A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffeiMedicine, 2015
- Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesionsBMC Infectious Diseases, 2015
- Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapiesHaematologica, 2014
- International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaLeukemia, 2009
- Immunodeficiency and immunotherapy in multiple myelomaBritish Journal of Haematology, 2007
- Lymphadenopathy Due to Penicillium Marneffei Infection: Diagnosis by Fine Needle Aspiration CytologyLaboratory Investigation, 2002
- Differences in Clinical and Laboratory Diagnostic Characteristics of Penicilliosis Marneffei in Human Immunodeficiency Virus (HIV)- and Non-HIV-Infected PatientsJournal of Clinical Microbiology, 2001
- Extramedullary PlasmacytomaActa Cytologica, 1997